세계의 신경외과 수술 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2032년)

Persistence Market Research has conducted a thorough analysis of the Neurosurgery Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the Neurosurgery Market spanning from 2024 to 2032.

The neurosurgery market's global revenue stood at US$ 4.37 billion by the close of 2024, projected to grow steadily with a compound annual growth rate (CAGR) of 4.5%. This trajectory is expected to propel the market to approximately US$ 7.9 billion by the conclusion of 2032.

Key Insights:

• Neurosurgery Market Size (2024): US$ 4.37 billion
• Projected Market Value (2032): US$ 7.9 billion
• Global Market Growth Rate (CAGR 2024-2032): 4.5%

Neurosurgery Market - Report Scope:

Neurosurgery involves surgical procedures aimed at treating conditions affecting the nervous system, including the brain, spinal cord, and peripheral nerves. The neurosurgery market encompasses a wide range of surgical techniques, devices, and technologies used in the diagnosis and treatment of neurological disorders. Key segments include neurostimulation devices, neuroendoscopy systems, neurosurgical navigation systems, and neurointerventional devices.

Market growth is driven by factors such as the increasing prevalence of neurological disorders, advancements in surgical techniques and technologies, and growing demand for minimally invasive procedures. Additionally, rising healthcare expenditures, expanding geriatric population, and improving healthcare infrastructure in emerging economies contribute to market expansion.

Market Growth Drivers:

Increasing prevalence of neurological disorders such as stroke, epilepsy, Parkinson's disease, and brain tumors

Advancements in neuroimaging techniques, enabling accurate diagnosis and treatment planning

Growing adoption of minimally invasive neurosurgical procedures, reducing patient discomfort and recovery times

Rising demand for neurostimulation devices for the management of chronic pain, movement disorders, and psychiatric conditions

Expansion of healthcare infrastructure and the availability of specialized neurosurgical centers in developing regions

Market Restraints:

High cost associated with neurosurgical procedures and devices, limiting access in low-income regions

Stringent regulatory requirements for device approval, leading to extended time-to-market and higher development costs

Lack of skilled neurosurgeons and neurologists, particularly in rural and underserved areas

Concerns regarding the safety and efficacy of certain neurosurgical techniques and devices, leading to hesitancy among patients and healthcare providers

Market Opportunities:

Emerging applications of neurosurgery in the treatment of psychiatric disorders, movement disorders, and chronic pain conditions

Integration of artificial intelligence (AI) and machine learning (ML) technologies in neuroimaging and surgical navigation systems

Collaboration between industry stakeholders, research institutions, and healthcare providers to develop innovative neurosurgical solutions

Expansion of telemedicine and remote monitoring services, improving access to neurosurgical expertise in remote and underserved areas

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the neurosurgery market globally?
• Which neurosurgical techniques and devices are experiencing the highest demand and adoption rates?
• How are technological advancements reshaping the competitive landscape of the neurosurgery market?
• Who are the key players contributing to the neurosurgery market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global neurosurgery market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurosurgery market, including Medtronic plc, Stryker Corporation, Johnson & Johnson, and Integra LifeSciences Holdings Corporation, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in research and development to develop advanced neurosurgical devices and technologies, catering to the evolving needs of patients and healthcare providers.

Collaborations with neurology and neurosurgery centers, academic institutions, and government agencies facilitate market access and technology adoption. Moreover, emphasis on physician training, patient education, and clinical research promotes evidence-based practice and improves patient outcomes in the rapidly evolving field of neurosurgery.

Key Companies Profiled

• B. Braun Melsungen AG
• Medtronic plc
• DePuy Synthes
• Boston Scientific
• Stryker Corp.
• Terumo Corporation
• KARL STORZ GmbH & Co KG
• Integra LifeSciences
• Penumbra Inc
• Adeor Medical AG
• Elekta
• Clarus Medical
• MACHIDA ENDOSCOPE CO., LTD.

Key Segments Covered in Neurosurgery Industry Research

Neurosurgery Market by Product:

• Neuro Interventional Devices
• Neuroendoscopes
• Neurosurgical Drills
• Radiosurgery Systems
• Dura Substitutes
• Neurosurgery Instruments

Neurosurgery Market by End User:

• Hospitals
• Ambulatory Surgical Centers
• Specialized Neurological Institutes

Neurosurgery Market by Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply-Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions & Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Key Disease Epidemiology
• 4.2. Product Adoption / Usage Analysis
• 4.3. Product USPs / Features
• 4.4. Key Promotional Strategies, By Manufacturers
• 4.5. Porter's Analysis
• 4.6. PESTLE Analysis
• 4.7. Value Chain Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global Healthcare Market GDP and Growth Outlook
  • 5.1.2. Global Assistive Devices Market Overview
  • 5.1.3. Medical Device Industry Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. GDP Growth Forecast
  • 5.2.2. Ageing Population
  • 5.2.3. Growing Prevalence of Neurologic Diseases
  • 5.2.4. Growing Healthcare Expenditure
  • 5.2.5. Shift Towards Minimally Invasive Procedures
  • 5.2.6. Growing Research Efforts
  • 5.2.7. Cost Impact
  • 5.2.8. Entries Of New Start-Up Companies In The Market
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. Revenue By Product
  • 6.1.2. Revenue By End User
  • 6.1.3. Revenue by Country
• 6.2. 2024 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2019-2023 and Forecast, 2024-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2032
  • 8.3.1. Neuro Interventional Devices
    • 8.3.1.1. Neurovascular Embolization Devices
      • 8.3.1.1.1. Embolization Coils
      • 8.3.1.1.2. Liquid Embolic Systems
      • 8.3.1.1.3. Flow Diversion Stents
      • 8.3.1.1.4. Aneurysm Clips
    • 8.3.1.2. Neurovascular Coiling Assist Devices
      • 8.3.1.2.1. Coiling Assist Stents
      • 8.3.1.2.2. Coiling Assist Balloons
    • 8.3.1.3. Neurovascular Thrombectomy Devices
      • 8.3.1.3.1. Stent Retrievers
      • 8.3.1.3.2. Aspiration Retrievers
    • 8.3.1.4. Microguidewires
    • 8.3.1.5. Microcatheters
    • 8.3.1.6. Support Catheters
    • 8.3.1.7. Intracranial Stents
  • 8.3.2. Neuroendoscopes
    • 8.3.2.1. Flexible Neuroendoscopes
    • 8.3.2.2. Rigid Neuroendoscopes
  • 8.3.3. Neurosurgical Drills
    • 8.3.3.1. Pneumatic Neurosurgical Drills
    • 8.3.3.2. Electrical Neurosurgical Drills
  • 8.3.4. Radiosurgery Systems
    • 8.3.4.1. Linear Accelerator Radiosurgery Systems
    • 8.3.4.2. Gamma Knife Radiosurgery Systems
  • 8.3.5. Dura Substitutes
    • 8.3.5.1. Biological Dura Substitutes
    • 8.3.5.2. Synthetic Dura Substitutes
  • 8.3.6. Neurosurgical Ablation Devices
    • 8.3.6.1. MRI Guided Focused Ultrasound Systems
    • 8.3.6.2. MRI Guided Laser Therapy Systems
    • 8.3.6.3. MRI Guided RF Ablation Systems
  • 8.3.7. Neurosurgery Instruments
    • 8.3.7.1. Tissue Retractors
    • 8.3.7.2. Forceps
    • 8.3.7.3. Head Frames
    • 8.3.7.4. Cervical Plating systems
    • 8.3.7.5. Perforators
• 8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, By End User

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2032
  • 9.3.1. Hospitals
  • 9.3.2. Ambulatory Surgical Centers
  • 9.3.3. Specialized Neurological Institutes
• 9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032, by Region

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2032
  • 10.3.1. North America
  • 10.3.2. Latin America
  • 10.3.3. Europe
  • 10.3.4. East Asia
  • 10.3.5. South Asia
  • 10.3.6. Oceania
  • 10.3.7. Middle East and Africa (MEA)
• 10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 11.3.1. By Country
    • 11.3.1.1. U.S.
    • 11.3.1.2. Canada
  • 11.3.2. By Product
  • 11.3.3. By End User
• 11.4. Market Attractiveness Analysis
  • 11.4.1. By Country
  • 11.4.2. By Product
  • 11.4.3. By End User
• 11.5. Market Trends
• 11.6. Key Market Participants - Intensity Mapping
• 11.7. Drivers and Restraints - Impact Analysis
• 11.8. Country Level Analysis & Forecast
  • 11.8.1. U.S. Neurosurgery Market
    • 11.8.1.1. Introduction
    • 11.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 11.8.1.2.1. By Product
      • 11.8.1.2.2. By End User
  • 11.8.2. Canada Neurosurgery Market
    • 11.8.2.1. Introduction
    • 11.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 11.8.2.2.1. By Product
      • 11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 12.3.1. By Country
    • 12.3.1.1. Brazil
    • 12.3.1.2. Argentina
    • 12.3.1.3. Mexico
    • 12.3.1.4. Rest of Latin America
  • 12.3.2. By Product
  • 12.3.3. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By End User
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping
• 12.7. Drivers and Restraints - Impact Analysis
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. Brazil Neurosurgery Market
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By End User
  • 12.8.2. Mexico Neurosurgery Market
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By End User
  • 12.8.3. Argentina Neurosurgery Market
    • 12.8.3.1. Introduction
    • 12.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.3.2.1. By Product
      • 12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 13.3.1. By Country
    • 13.3.1.1. Germany
    • 13.3.1.2. France
    • 13.3.1.3. Italy
    • 13.3.1.4. Spain
    • 13.3.1.5. UK
    • 13.3.1.6. BENELUX
    • 13.3.1.7. Russia
    • 13.3.1.8. Nordic Countries
    • 13.3.1.9. Rest of Europe
  • 13.3.2. By Product
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By End User
• 13.5. Market Trends
• 13.6. Key Market Participants - Intensity Mapping
• 13.7. Drivers and Restraints - Impact Analysis
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Germany Neurosurgery Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By End User
  • 13.8.2. Italy Neurosurgery Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By End User
  • 13.8.3. France Neurosurgery Market
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By End User
      • 13.8.3.2.3.
  • 13.8.4. Spain Neurosurgery Market
    • 13.8.4.1. Introduction
    • 13.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.4.2.1. By Product
      • 13.8.4.2.2. By End User
  • 13.8.5. U.K. Neurosurgery Market
    • 13.8.5.1. Introduction
    • 13.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.5.2.1. By Product
      • 13.8.5.2.2. By End User
  • 13.8.6. Benelux Union Neurosurgery Market
    • 13.8.6.1. Introduction
    • 13.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.6.2.1. By Product
      • 13.8.6.2.2. By End User
  • 13.8.7. Nordic Countries Neurosurgery Market
    • 13.8.7.1. Introduction
    • 13.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.7.2.1. By Product
      • 13.8.7.2.2. By End User
  • 13.8.8. Russia Neurosurgery Market
    • 13.8.8.1. Introduction
    • 13.8.8.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.8.2.1. By Product
      • 13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 14.3.1. By Country
    • 14.3.1.1. India
    • 14.3.1.2. Indonesia
    • 14.3.1.3. Malaysia
    • 14.3.1.4. Thailand
    • 14.3.1.5. Rest of South Asia
  • 14.3.2. By Product
  • 14.3.3. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By End User
• 14.5. Market Trends
• 14.6. Key Market Participants - Intensity Mapping
• 14.7. Drivers and Restraints - Impact Analysis
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. India Neurosurgery Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By End User
  • 14.8.2. Indonesia Neurosurgery Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By End User
  • 14.8.3. Malaysia Neurosurgery Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By End User
  • 14.8.4. Thailand Neurosurgery Market
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By End User
• 15.5. Market Trends
• 15.6. Key Market Participants - Intensity Mapping
• 15.7. Drivers and Restraints - Impact Analysis
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Neurosurgery Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By End User
  • 15.8.2. Japan Neurosurgery Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By End User
  • 15.8.3. South Korea Neurosurgery Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 16.3.1. By Country
    • 16.3.1.1. Australia
    • 16.3.1.2. New Zealand
  • 16.3.2. By Product
  • 16.3.3. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By End User
• 16.5. Market Trends
• 16.6. Key Market Participants - Intensity Mapping
• 16.7. Drivers and Restraints - Impact Analysis
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Australia Neurosurgery Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By End User
  • 16.8.2. New Zealand Neurosurgery Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2019-2023 and Forecast 2024-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2032
  • 17.3.1. By Country
    • 17.3.1.1. GCC Countries
    • 17.3.1.2. Turkey
    • 17.3.1.3. Israel
    • 17.3.1.4. Northern Africa
    • 17.3.1.5. South Africa
    • 17.3.1.6. Rest of Middle East and Africa
  • 17.3.2. By Product
  • 17.3.3. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By End User
• 17.5. Market Trends
• 17.6. Key Market Participants - Intensity Mapping
• 17.7. Drivers and Restraints - Impact Analysis
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. GCC Countries Neurosurgery Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By End User
  • 17.8.2. Turkey Neurosurgery Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By End User
  • 17.8.3. North Africa Neurosurgery Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By End User
  • 17.8.4. South Africa Neurosurgery Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By End User

18. Market Structure Analysis

• 18.1. Market Analysis by Tier of Companies
• 18.2. Market Share Analysis of Top Players
• 18.3. Market Presence Analysis

19. Competition Analysis

• 19.1. Competition Dashboard
• 19.2. Competition Benchmarking
• 19.3. Competition Deep Dive
  • 19.3.1. Stryker Corp.
    • 19.3.1.1. .Overview
    • 19.3.1.2. Product Portfolio
    • 19.3.1.3. Key Financials
    • 19.3.1.4. SWOT Analysis
    • 19.3.1.5. Key Developments
    • 19.3.1.6. Sales Footprint
    • 19.3.1.7. Strategy Overview
      • 19.3.1.7.1. Marketing Strategy
      • 19.3.1.7.2. Product Strategy
      • 19.3.1.7.3. Channel Strategy
  • 19.3.2. B. Braun Melsungen AG
    • 19.3.2.1. Overview
    • 19.3.2.2. Product Portfolio
    • 19.3.2.3. Key Financials
    • 19.3.2.4. SWOT Analysis
    • 19.3.2.5. Key Developments
    • 19.3.2.6. Sales Footprint
    • 19.3.2.7. Strategy Overview
      • 19.3.2.7.1. Marketing Strategy
      • 19.3.2.7.2. Product Strategy
      • 19.3.2.7.3. Channel Strategy
  • 19.3.3. Medtronic plc
    • 19.3.3.1. Overview
    • 19.3.3.2. Product Portfolio
    • 19.3.3.3. Key Financials
    • 19.3.3.4. SWOT Analysis
    • 19.3.3.5. Key Developments
    • 19.3.3.6. Sales Footprint
    • 19.3.3.7. Strategy Overview
      • 19.3.3.7.1. Marketing Strategy
      • 19.3.3.7.2. Product Strategy
      • 19.3.3.7.3. Channel Strategy
  • 19.3.4. DePuy Synthes
    • 19.3.4.1. Overview
    • 19.3.4.2. Product Portfolio
    • 19.3.4.3. Key Financials
    • 19.3.4.4. SWOT Analysis
    • 19.3.4.5. Key Developments
    • 19.3.4.6. Sales Footprint
    • 19.3.4.7. Strategy Overview
      • 19.3.4.7.1. Marketing Strategy
      • 19.3.4.7.2. Product Strategy
      • 19.3.4.7.3. Channel Strategy
  • 19.3.5. Boston Scientific
    • 19.3.5.1. Overview
    • 19.3.5.2. Product Portfolio
    • 19.3.5.3. Key Financials
    • 19.3.5.4. SWOT Analysis
    • 19.3.5.5. Key Developments
    • 19.3.5.6. Sales Footprint
    • 19.3.5.7. Strategy Overview
      • 19.3.5.7.1. Marketing Strategy
      • 19.3.5.7.2. Product Strategy
      • 19.3.5.7.3. Channel Strategy
  • 19.3.6. Terumo Corporation
    • 19.3.6.1. Overview
    • 19.3.6.2. Product Portfolio
    • 19.3.6.3. Key Financials
    • 19.3.6.4. SWOT Analysis
    • 19.3.6.5. Key Developments
    • 19.3.6.6. Sales Footprint
    • 19.3.6.7. Strategy Overview
      • 19.3.6.7.1. Marketing Strategy
      • 19.3.6.7.2. Product Strategy
      • 19.3.6.7.3. Channel Strategy
  • 19.3.7. KARL STORZ GmbH & Co KG
    • 19.3.7.1. Overview
    • 19.3.7.2. Product Portfolio
    • 19.3.7.3. Key Financials
    • 19.3.7.4. SWOT Analysis
    • 19.3.7.5. Key Developments
    • 19.3.7.6. Sales Footprint
    • 19.3.7.7. Strategy Overview
      • 19.3.7.7.1. Marketing Strategy
      • 19.3.7.7.2. Product Strategy
      • 19.3.7.7.3. Channel Strategy
  • 19.3.8. Integra LifeSciences
    • 19.3.8.1. Overview
    • 19.3.8.2. Product Portfolio
    • 19.3.8.3. Key Financials
    • 19.3.8.4. SWOT Analysis
    • 19.3.8.5. Key Developments
    • 19.3.8.6. Sales Footprint
    • 19.3.8.7. Strategy Overview
      • 19.3.8.7.1. Marketing Strategy
      • 19.3.8.7.2. Product Strategy
      • 19.3.8.7.3. Channel Strategy
  • 19.3.9. Penumbra Inc
    • 19.3.9.1. Overview
    • 19.3.9.2. Product Portfolio
    • 19.3.9.3. Key Financials
    • 19.3.9.4. SWOT Analysis
    • 19.3.9.5. Key Developments
    • 19.3.9.6. Sales Footprint
    • 19.3.9.7. Strategy Overview
      • 19.3.9.7.1. Marketing Strategy
      • 19.3.9.7.2. Product Strategy
      • 19.3.9.7.3. Channel Strategy
  • 19.3.10. Adeor Medical AG
    • 19.3.10.1. Overview
    • 19.3.10.2. Product Portfolio
    • 19.3.10.3. Key Financials
    • 19.3.10.4. SWOT Analysis
    • 19.3.10.5. Key Developments
    • 19.3.10.6. Sales Footprint
    • 19.3.10.7. Strategy Overview
      • 19.3.10.7.1. Marketing Strategy
      • 19.3.10.7.2. Product Strategy
      • 19.3.10.7.3. Channel Strategy
  • 19.3.11. Elekta
    • 19.3.11.1. Overview
    • 19.3.11.2. Product Portfolio
    • 19.3.11.3. Key Financials
    • 19.3.11.4. SWOT Analysis
    • 19.3.11.5. Key Developments
    • 19.3.11.6. Sales Footprint
    • 19.3.11.7. Strategy Overview
      • 19.3.11.7.1. Marketing Strategy
      • 19.3.11.7.2. Product Strategy
      • 19.3.11.7.3. Channel Strategy
  • 19.3.12. Clarus Medical
    • 19.3.12.1. Overview
    • 19.3.12.2. Product Portfolio
    • 19.3.12.3. Key Financials
    • 19.3.12.4. SWOT Analysis
    • 19.3.12.5. Key Developments
    • 19.3.12.6. Sales Footprint
    • 19.3.12.7. Strategy Overview
      • 19.3.12.7.1. Marketing Strategy
      • 19.3.12.7.2. Product Strategy
      • 19.3.12.7.3. Channel Strategy
  • 19.3.13. MACHIDA ENDOSCOPE CO., LTD.
    • 19.3.13.1. Overview
    • 19.3.13.2. Product Portfolio
    • 19.3.13.3. Key Financials
    • 19.3.13.4. SWOT Analysis
    • 19.3.13.5. Key Developments
    • 19.3.13.6. Sales Footprint
    • 19.3.13.7. Strategy Overview
      • 19.3.13.7.1. Marketing Strategy
      • 19.3.13.7.2. Product Strategy
      • 19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology